mexiletine has been researched along with Heart Septal Defects, Ventricular in 1 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shakibi, JG | 1 |
| Moezzi, B | 1 |
1 other study available for mexiletine and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
Electrophysiologic effects of mexiletine in children.
Topics: Adolescent; Arrhythmias, Cardiac; Atrioventricular Node; Bundle of His; Child; Child, Preschool; Fem | 1982 |